Changing mindsets about methotrexate in the rheumatology clinic to reduce side effects and improve adherence: a randomized controlled trial
In patients starting methotrexate, a mindset intervention reframing the role of non-severe side effects is a promising approach for improving symptom experience and early stage medication persistence.
Authors
- Kari Leibowitz (ORCID: https://orcid.org/0000-0001-7494-7270)
- Rachael Yielder (ORCID: https://orcid.org/0000-0002-1644-1762)
- Alia J. Crum (ORCID: https://orcid.org/0000-0002-0892-1811)
- Keith J. Petrie (ORCID: https://orcid.org/0000-0002-6337-2480)
- Nicola Dalbeth (ORCID: https://orcid.org/0000-0003-4632-4476)
- Paul Manley
Institutions
- University of Auckland (NZ)
- Stanford University (US)
Publication Details
- Journal
- Annals of Behavioral Medicine
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1093/abm/kaae089
- Citations
- 8
- Primary Topic
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Type
- article
- Field-Weighted Citation Impact
- 4.06